DA

Dinesh Agarwal

Active Director Director DIN 01068106
DIN 01068106 First appointment Apr 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 1999
Shareholding value •••• Premium profile

About Dinesh Agarwal

Data last updated:

Dinesh Agarwal is a Director at Kaiser Drugs Private Limited (since 1999). The company operates in Pharma. Kaiser Drugs Private Limited reported revenue of ₹9.89 Cr (FY 2025).

DIN 01068106
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 1999
Oldest Company Age 27 yrs
Largest company Kaiser Drugs Private Limited · ₹9.89 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kaiser Drugs Private Limited U85110UP1999PTC024379
Director26 Apr 19991999₹9.89 Cr (FY 2025)Active

Board colleagues of Dinesh Agarwal

Directorship timeline

Open interactive timeline →
Kaiser Drugs Private Limited
Premium access

Shareholding and investment profile for Dinesh Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Agarwal

Dinesh Agarwal currently holds 1 directorship: Kaiser Drugs Private Limited (Director, since 26 Apr 1999, revenue ₹9.89 Cr (FY 2025)).

Dinesh Agarwal was first appointed on 26 Apr 1999 as Director at Kaiser Drugs Private Limited.

The current boards of Dinesh Agarwal's companies include Archana Agarwal (Kaiser Drugs Private Limited), Naresh Agarwal (Kaiser Drugs Private Limited), Vijay Laxmi Agarawal (Kaiser Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available